High Rate of Waning Botox Efficacy in Dystonia, Spasticity

A ‘surprisingly high’ number of patients with dystonia or spasticity who receive botulinum neurotoxin type A develop neutralizing antibodies to the toxin over time, new research shows.
Medscape Medical News

Source link

Related posts

The most useful investigative tools of neurology


Doubts about TMEM230 as a gene for parkinsonism


Friendship Bench—A Model for Accessible Mental Health Care


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy